Yahoo Web Search

    • Cytocom, Inc. Issues Shareholder Letter

      TheStreet.com· 4 days ago

      Cytocom, Inc., a leading biopharmaceutical company in the area of immune-modulation, today announced that its Chief Executive Officer, Michael K. Handley, has issued a Letter to the stockholders ...